113 reports of this reaction
3.7% of all PHOSPHORIC ACID reports
#3 most reported adverse reaction
ORTHOSTATIC HYPOTENSION is the #3 most commonly reported adverse reaction for PHOSPHORIC ACID, manufactured by BM Private Limited. There are 113 FDA adverse event reports linking PHOSPHORIC ACID to ORTHOSTATIC HYPOTENSION. This represents approximately 3.7% of all 3,032 adverse event reports for this drug.
Patients taking PHOSPHORIC ACID who experience orthostatic hypotension should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ORTHOSTATIC HYPOTENSION is moderately reported among PHOSPHORIC ACID users, representing a notable but not dominant share of adverse events.
In addition to orthostatic hypotension, the following adverse reactions have been reported for PHOSPHORIC ACID:
The following drugs have also been linked to orthostatic hypotension in FDA adverse event reports:
ORTHOSTATIC HYPOTENSION has been reported as an adverse event in 113 FDA reports for PHOSPHORIC ACID. This does not prove causation, but indicates an association observed in post-market surveillance data.
ORTHOSTATIC HYPOTENSION accounts for approximately 3.7% of all adverse event reports for PHOSPHORIC ACID, making it one of the most commonly reported side effect.
If you experience orthostatic hypotension while taking PHOSPHORIC ACID, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.